Almac secures grant to scale COVID-19 drug production
The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.
The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.
The decentralized trial tech firm’s Verisense inertial measurement unit sensor has received the seal of approval from the Conformitè Europëenne.
The new EU Pharmaceutical Strategy, adopted today by the European Commission, is designed to improve and accelerate patients’ access to safe and affordable medicines and address unmet medical needs in the areas of antimicrobial resistance, cancer, and...
The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.